cytokinetics

On target clinical trial success bullseye score

Pharma

Cytokinetics scores with Myqorzo in key cardiomyopathy trial

Cytokinetics has aced a phase 3 trial of Myqorzo in non-obstructive hypertrophic cardiomyopathy. It is the first successful study in the indication.

Kevin Dunleavy May 5, 2026 8:00am

Bristol Myers Squibb

Trial win for BMS sets up Camzyos for pediatric expansion

Jan 12, 2026 10:25am

green light go go ahead advance yes streetlight

Cytokinetics scores its first FDA nod with Myqorzo approval

Dec 22, 2025 12:05pm

Silhouette of Businessman Entering Lit Door Passage in Darkness

Fierce Biotech

Cytokinetics doesn't want Big Pharma help to overtake Camzyos

Nov 18, 2025 1:30pm

Stethoscope and red heart with pink background

Cytokinetics joins Bristol Myers in funding heart registry

Nov 17, 2025 12:45pm

Asia

China cuts, CSL site closure and Kyowa deal—Fierce Pharma Asia

Nov 22, 2024 3:00am